Table 5.

Summary of most frequently reported drug-related clinical adverse events^* (≥10% of subjects)

	APL N = 24	LPV/r N = 23	APL + LPV/r N = 22
Any event	12/24 (50%)	11/23 (48%)	11/22 (50%)
Gastrointestinal
Loose stools	11/24 (46%)	4/23 (17%)	5/23 (23%)
Nausea	5/24 (21%)	4/23 (17%)	7/22 (32%)
Abdominal pain	1/24 (4%)	4/23 (17%)	1/22 (5%)
Vomiting	0/24 (0%)	0/23 (0%)	3/22 (14%)
Diarrhoea	1/24 (4%)	4/23 (17%)	0/22 (0%)
Metabolism and nutrition
Anorexia	0/24 (0%)	0/23 (0%)	4/22 (18%)

^*All adverse events classified as grade 1. APL, Aplaviroc; LPV, lopinavir.